Resonant, a Renew Biotechnologies subsidiary developing novel diagnostic tools for neurodegenerative diseases, announces the ...

Simply put, Illumina tends to have better profitability ratios compared to its peers. For instance, Illumina has a 68.38% ...

"Fueled by advances in NGS and precision medicine, China’s DNA sequencing market sees rapid growth amid strong government support, rising clinical applications, and innovation hubs in Guangdong, ...

Illumina Inc. said the Chinese government has lifted a ban on the company selling its DNA sequencing machines inside the country.

China is set to ease restrictions on some Illumina products, giving the sequencing giant a partial reprieve. | China is set to ease restrictions on some Illumina products, giving the sequencing giant ...

Shares in Oxford Nanopore Technologies jumped on Friday after the company revealed that annual revenue growth would be at the top end of forecasts.

ITV on Friday confirmed it was in preliminary discussions regarding a possible sale of its broadcasting business to Comcast-owned Sky for an enterprise value of £1.6bn, sending shares in the company ...

(Alliance News) - Oxford Nanopore Technologies PLC shares surged on Friday as it set out upbeat guidance for the full-year. The Oxford-based specialist in DNA and RNA sequencing technologies said 2025 ...

A team of scientists is employing a technique used to detect invasive species to search for troops lost at sea.

Oxford Nanopore is moving ahead with plans for an initial public offering (IPO) and has now hired banks to manage the process, two sources familiar with the matter told Reuters, in a further boost to ...

At the booth of Gilead Sciences, Lenacapavir, to be used as the world's only twice-yearly, long-acting injectable for HIV ...

Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic ...